A Nuclear Factor-.KAPPA.B Inhibitor BAY 11-7082 Suppresses Endothelin-1 Production in Cultured Vascular Endothelial Cells.

  • Ohkita Mamoru
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences
  • Takaoka Masanori
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences
  • Shiota Yasuko
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences
  • Nojiri Rumi
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences
  • Sugii Masato
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences
  • Matsumura Yasuo
    Department of Pharmacology, Osaka University of Pharmaceutical Sciences

Bibliographic Information

Other Title
  • A Nuclear Factor-kB Inhibitor BAY 11-7082 Suppresses Endothelin-1 Production in Cultured Vascular Endothelial Cells
  • A Nuclear Factor-κdB Inhibitor BAY 11-7082 Suppresses Endothelin-1 Production in Cultured Vascular Endothelial Cells
  • A nuclear factor-κB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells
  • A nuclear factor-κB inhibitor BAY 11‐7082 suppresses endothelin-1 production in cultured vascular endothelial cells

Search this article

Abstract

BAY 11-7082, an inhibitor of nuclear factor-κB (NF-κB), which prevents a step of the phosphorylation of inhibitory protein IκB bound to NF-κB, suppressed basal and tumor necrosis factor (TNF)-α-induced prepro endothelin (ET)-1 mRNA expression and NF-κB activation in cultured vascular endothelial cells. BAY 11-7082 significantly decreased basal and TNF-α-induced ET-1 release from endothelial cells. These results indicate that the inhibition of NF-κB activation contributes to the suppressive effect of BAY 11-7082 on ET-1 gene expression and ET-1 release, thereby suggesting that NF-κB plays an important role in the regulation of ET-1 production.

Journal

Citations (5)*help

See more

References(25)*help

See more

Details 詳細情報について

Report a problem

Back to top